<DOC>
	<DOCNO>NCT00003372</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness topotecan treating patient recurrent brain tumor .</brief_summary>
	<brief_title>Topotecan Treating Patients With Recurrent Brain Tumors</brief_title>
	<detailed_description>OBJECTIVES : I . Determine efficacy topotecan patient recurrent anaplastic oligodendroglioma anaplastic mixed oligoastrocytoma . II . Determine qualitative quantitative toxicity topotecan patient population schedule . OUTLINE : This multicenter study . Patients receive intravenous topotecan 30 minute daily 5 day every 3 week . Treatment continue absence disease progression unacceptable toxicity . Patients follow every 3 month death . PROJECTED ACCRUAL : Up 30 evaluable patient accrue within 2-3 year .</detailed_description>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Oligodendroglioma</mesh_term>
	<mesh_term>Topotecan</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven recurrent anaplastic oligodendroglioma anaplastic mixed oligoastrocytoma follow primary surgery radiation therapy Tumors anaplastic mixed oligoastrocytoma must contain least 25 % oligodendroglial element Tumors must clinically aggressive patient 1 anaplastic feature Prior low grade oligodendrogliomas oligoastrocytomas undergo repeat biopsy follow clinical radiological progression eligible Bidimensionally measurable progressive lesion CT MRI PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 03 Life expectancy : Not specify Hematopoietic : Absolute granulocyte count least 1,500/mm3 Platelet count least 100,000/mm3 Hepatic : Not specify Renal : Creatinine normal Other : Not pregnant nursing Fertile patient must use effective contraception No prior malignancy except curatively treat carcinoma situ cervix nonmelanoma skin cancer No serious illness medical condition No active uncontrolled infection No history neurologic psychiatric disorder PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : At least 6 week since chemotherapy No 1 prior chemotherapy regimen No prior camptothecin derivative Endocrine therapy : At least 2 week stable steroid therapy , necessary Radiotherapy : At least 2 month since prior radiotherapy No prior radiation therapy recurrent disease Surgery : At least 6 week since prior surgery ( except biopsy ) Prior surgery recurrent disease allow ( include stereotactic biopsy partial resection ) Other : No concurrent experimental drug anticancer therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>recurrent adult brain tumor</keyword>
	<keyword>adult anaplastic oligodendroglioma</keyword>
	<keyword>adult mixed glioma</keyword>
</DOC>